Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Invest Radiol. 2011 Jan;46(1):41–47. doi: 10.1097/RLI.0b013e3181f0213f

Table 3.

Renal basal cortical and medullary tissue oxygenation, pO2 (mmHg) determined using intra-renal O2 probes at baseline and following administration of saline (s), acetazolamide (az), and/or furosemide (furo) in each experimental period.

Cortex Medulla
Baseline Period 1 Period 2 Baseline Period 1 Period 2
s+s 44.1 ± 1.8 46.4 ± 2.1 44.3 ± 1.3 23.5 ± 0.9 25.1 ± 2.0 25.8 ± 2.6
s+az 45.4 ± 2.4 44.7 ± 2.2 53.5 ± 1.6*† 24±1.4 23.1 ± 0.9 30.3 ± 2.5
furo+s 45.6± 1.6 50.2 ± 1.2 50.1 ± 1.3 23.5±0.9 38.5 ± 1.1* 40.8 ± 0.8*
furo+az 47.2±0.8 48.3 ± 0.9 57.3 ± 0.7*† 26.8±1.1 39.4 ±1.7* 40.6 ±2.6*

s: saline, az: acetazolamide, furo: furosemide

*

p<0.01 vs. baseline pO2

†

p<0.01 vs. period 1